CAS: 1809010-50-1
Berotralstat
CAS:1809010-50-1
Berotralstat (BCX7353) is an oral, low-toxicity, specific kallikrein inhibitor for hereditary angioedema research, blocking bradykinin …
Formula:
C30H26F4N6O
Color and Shape:
Liquid
Molecular weight:
562.573
Ref: TM-T35869
| 25mg | 1,422.00 € | ||
| 50mg | 1,852.00 € | ||
| 100mg | 2,339.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Ref: 4Z-B-209010
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 23 Dec 2024
Ref: 4Z-B-209001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 23 Dec 2024
Berotralstat
Controlled ProductCAS:1809010-50-1
Formula:
C30H26F4N6O
Color and Shape:
Neat
Molecular weight:
562.561
Ref: TR-B485510
| 75mg | 20,168.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Berotralstat
CAS:1809010-50-1
Berotralstat is an anticancer drug that inhibits the activity of kinases, which are enzymes that …
Formula:
C30H26F4N6O
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
562.6 g/mol
Ref: 3D-JXC01050
| 1mg | 986.00 € | ||
| 2mg | 1,623.00 € | ||
| 5mg | 2,319.00 € | ||
| 10mg | 3,710.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
